Company Filing History:
Years Active: 2017-2020
Title: Anjaneyaraju Indukuri: Innovator in Pharmaceutical Patents
Introduction
Anjaneyaraju Indukuri is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of important drugs. With a total of four patents to his name, Indukuri's work is recognized for its impact on drug formulation and delivery.
Latest Patents
Among his latest patents, Indukuri has developed polymorphic forms of VENCLEXTA, which relates to crystalline forms of venetoclax and the processes for their preparation. This innovation also includes a method for preparing amorphous venetoclax. Additionally, he has worked on polymorphic forms of sofosbuvir, providing a novel crystalline sofosbuvir form-M3 and a process for its preparation. The crystalline sofosbuvir form-M3 is particularly noteworthy as it may be useful in the formulation of pharmaceutical dosage forms.
Career Highlights
Indukuri is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His role at Mylan has allowed him to focus on innovative drug formulations that enhance therapeutic efficacy and patient compliance. His expertise in the field has positioned him as a valuable asset to the company and the pharmaceutical industry at large.
Collaborations
Indukuri has collaborated with several professionals in his field, including Ramakoteswara Rao Jetti and Hemant Malhari Mande. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of his patented technologies.
Conclusion
Anjaneyaraju Indukuri's contributions to pharmaceutical innovations through his patents exemplify the importance of research and development in the healthcare sector. His work continues to influence drug formulation practices, making a significant impact on patient care and treatment options.